RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 69 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $868,000 | +56.1% | 96,800 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $556,000 | +13.2% | 103,500 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $491,000 | -16.6% | 106,800 | -5.7% | 0.00% | 0.0% |
| Q4 2015 | $589,000 | -14.0% | 113,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $685,000 | -61.7% | 113,300 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $1,789,000 | +66.7% | 113,300 | -4.1% | 0.00% | +200.0% |
| Q1 2015 | $1,073,000 | 0.0% | 118,200 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,073,000 | -7.0% | 118,200 | -1.7% | 0.00% | -50.0% |
| Q3 2014 | $1,154,000 | -11.8% | 120,300 | +6.2% | 0.00% | 0.0% |
| Q2 2014 | $1,309,000 | +29.1% | 113,300 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $1,014,000 | +62.5% | 113,300 | +148.5% | 0.00% | 0.0% |
| Q4 2013 | $624,000 | -13.3% | 45,600 | -5.4% | 0.00% | 0.0% |
| Q3 2013 | $720,000 | +183.5% | 48,200 | +77.6% | 0.00% | 0.0% |
| Q2 2013 | $254,000 | – | 27,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |